Regulatory

(Image: Getty/scanrail)

Scaling down: Clinical research shifts its focus

By Maggie Lynch

Smaller company’s last year led in new drug approvals, nearly half of which were for the treatment of rare diseases, as the industry shifts away from the need to scale infrastructure, says Tufts director.

(Image: Getty/KatarynaBalasiewicz)

Guest Column

Making the most of patient engagement

By Barbara Lopez Kunz, global chief executive, DIA

The practice of incorporating the voice of the patient into clinical development has gained significant traction over the past decade, and rightfully so.

Spotlight

Follow us

Products

View more

Webinars

Featured Suppliers

All suppliers